Aclaris Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (48)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
Article By: ChinaBio® Today
Sunday, December 4, 2022 2:29 PM EDT
Full-Life Technologies, a Brussels-Shanghai radiotherapeutics company, will acquire Focus-X Therapeutics for up to $245 million. Using its proprietary peptide engineering technology, Focus-X has built a portfolio of eight radiopharmaceuticals.
In this article: LLY, ACRS, ADCT
Read
US And Canadian Stock Swing Trading Watchlist - Wednesday, Mar. 17
Article By: Cory Mitchell, CMT
Wednesday, March 17, 2021 6:12 PM EDT
The stock market is healthy and rising (not a forecast). The Nasdaq 100 was lagging for a bit, but it is once again running higher as well.
In this article: BW, SID, CVGI, NDX, SPX, SGRY, ACRS, MARA, GBOX, QMCO
Read
Morning Call For Thursday, Oct. 18
Article By: Jim Van Meerten
Thursday, October 18, 2018 7:58 AM EDT
Dec E-mini S&Ps (ESZ18 -0.39%) this morning are down -0.38% and the 10-year T-note yield climbed to a 1-week high of 3.21% on signs the Fed will continue to raise interest rates into next year.
In this article: AA, FLR, GPS, PTI, SEE, STZ, KALU, CHRW, TCBI, OMED, ACRS, ZG, FSCT, KRYS
Read
Morning Call For Thursday, Nov. 17
Article By: Jim Van Meerten
Thursday, November 17, 2016 9:01 AM EDT
Dec E-mini S&Ps (ESZ16 +0.14%) are up +0.09% and European stocks are down -0.02%, both little changed ahead of Fed Chair Yellen's testimony this morning before the Joint Economic Committee of Congress.
In this article: CMG, FSLR, AMGN, CSCO, MSFT, NTAP, SHOP, LB, EQM, PLNT, PFGC, ACRS
Read
CytomX Long Term Returns Uncertain
Article By: Don Dion
Tuesday, October 6, 2015 12:00 PM EDT
CTMX is the largest biotech this week to debut; investors could buy in at higher rates than slightly lower profile firms. CTMX has impressive partnerships with big pharma and is backed by Third Rock Ventures, Fidelity and Pfizer.
In this article: AZN, GSK, MRK, NVS, PFE, ROG, SNY, VRX, IDRA, IMGN, NLNK, SGEN, CELG, JUNO, KITE, BLUE, BLCM, ACRS
Read
All Posts

Latest Tweets for $ACRS

No tweets yet!

PARTNER HEADLINES